Firm seeks effective treatment for Sickle Cell Disease
Oklahoma-based EpimedX may be nearing a treatment for Sicle Cell Disease.
DID YOU KNOW?
If both parents have the sickle cell gene, there is a one in four chance of having a baby with Sickle Cell Disease. Eighty-five percent of the approximately 100,000 SCD sufferers in the U.S. are black, 10.6 percent are American Indian, and 4.4 percent are Hispanic-American, Asian-American, or Caucasian.
Broyles and EpimedX co-founder Robert Floyd are building the firm's first investment round. The funds will be used to complete preclinical tests and file the drug with the FDA. The next funding round will be for clinical trials.
Thanks to the perseverance of the EpimedX scientists and entrepreneurs, this Oklahoma firm is on a path to bring relief to Sickle Cell Disease sufferers around the world.
Rex Smitherman is interim president and CEO of i2E Inc., a nonprofit corporation that mentors many of the state's technology-based startup companies. i2E receives state appropriations from the Oklahoma Center for the Advancement of Science and Technology. Contact Smitherman at i2E_Comments@i2E.org.
Business Photo Galleriesview all
- 13758Oklahoma tornadoes: The 'Big Dog,' the little boy and the hug that triumphs over tragedy
- 9630Finding Addyson – One family's struggle in the Moore tornado
- 9095Oklahoma tornadoes: Cost, custom keep basements scarce
- 8238Oklahoma tornadoes: Plaza Towers Elementary School teacher shoved students into bathroom as wall collapsed
- 6533Miranda Lambert, Reba McEntire, Vince Gill to join Blake Shelton at "Healing in the Heartland" Oklahoma tornado benefit
- 6005Oklahoma tornadoes: Woman meets the military officer who shared the clothes off his back
- 5369Story behind the photo: Family members describe desperate search for one another after EF5 twister